1. Home
  2. ARI vs CTMX Comparison

ARI vs CTMX Comparison

Compare ARI & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

N/A

Current Price

$6.54

Market Cap

884.4M

Sector

Real Estate

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$2.76

Market Cap

716.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARI
CTMX
Founded
2009
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.4M
716.9M
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
ARI
CTMX
Price
$6.54
$2.76
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$11.00
$12.10
AVG Volume (30 Days)
2.2M
3.5M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
9.31%
N/A
EPS Growth
183.51
N/A
EPS
0.27
N/A
Revenue
$271,589,000.00
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.61
P/E Ratio
$24.11
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$6.43
$1.90
52 Week High
$11.24
$8.21

Technical Indicators

Market Signals
Indicator
ARI
CTMX
Relative Strength Index (RSI) 27.48 29.17
Support Level $6.43 N/A
Resistance Level $7.00 $3.93
Average True Range (ATR) 0.10 0.22
MACD 0.02 -0.07
Stochastic Oscillator 2.33 2.05

Price Performance

Historical Comparison
ARI
CTMX

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: